A membrane invasion culture system was used to study the ability of EBV to enhance invasion and migration of nasopharyngeal carcinoma (NPC) cells. Semi-reverse transcriptase-PCR analysis of matrix proteinases and angiogenic factors from EBV-infected, or EBV-positive (EBVϩ), cells demonstrated different degrees of elevated gene expression. In our animal model, EBVϩ tumors grew faster and larger than EBV-free, or EBV-negative (EBVϪ), tumors and also had clonal EBV terminal repeat sequences. Double-localization of EBV and certain host proteins in EBVϩ tumors and biopsy specimens demonstrated that EBV up-regulates host genes only in cells that express those genes but not in cells that do not express them. Double-localization of EBV and host genes in NPC biopsy specimens all showed EBVϪ tumor cells expressing those host genes. Our data strongly suggest that EBV infection enhances progression of NPC tumor growth. They do not rule out a role for EBV infection in the induction and early promotion of NPC development. Unidentified factors may also enhance NPC tumor growth independent of the effects of EBV. (Lab Invest 2003, 83:797-812).
E
BV has been closely associated with nasopharyngeal carcinoma (NPC), one of the most common cancers in South China, Taiwan, and Singapore (Klein et al, 1974; Niedobitek et al, 1991; Raab-Traub et al, 1983; Waterhouse et al, 1982) . Heredity and environmental factors such as salted fish, Chinese herbs, and long-term exposure to sulfuric acid vapor may contribute to NPC induction (Armstrong et al, 1983; Ho et al, 1999) .
To better understand the relationship between EBV and NPC, we have established nine NPC cell lines (Lin et al, 1990 (Lin et al, , 1993 . Research findings regarding these cell lines and their original biopsy specimens can be summarized as follows (Lin et al, 1994 (Lin et al, , 1997a (Lin et al, , 1997b (Lin et al, , 2000 : (a) Only five of nine lines contained the EBV genome, and all lines became EBV-negative (EBVϪ) after 30 passages (Lin et al, 1994) ; (b) In EBV-positive (EBVϩ) lines, only a fraction of tumor cells contained the episomal form of EBV DNA (Lin et al, 1994) ; (c) In situ hybridization and in situ PCR hybridization of original biopsy specimens demonstrated geographic distribution of EBVϩ cells with a clonal expansion growth pattern. EBVϪ cells were present in each case, and no untransformed squamous metaplastic epithelial cells contained the EBV genome (Lin et al, 1994) ; (d) EBVϪ cells can be infected through EBV-IgAreceptor secretory component (SC) protein-mediated endocytosis in vitro (Lin et al, 1997a) ; (e) Doublelocalization of EBV and SC demonstrated individual tumor cells containing both EBV and SC signals in the same biopsy specimen (Lin et al, 1997a) ; (f) Clonal EBV terminal repeat DNA sequences occur when NPC cells are infected by EBV in vitro (Lin et al, 1997b) ; (g) EBV infection can up-regulate expression of certain growth factors or cytokines (epidermal growth factor receptor [EGFR] , transforming growth factor [TGF]-␣ , IL-1, IL-6, and granulocyte macrophage colony stimulating factor [GM-CSF]), but not of others (TGF-␤1 and its receptors, IL-2, IL-4, IL-5, IL-8, and TNF-␣) (Lin et al, 2000) ; and (h) Due to exocytosis of the EBV genome from host cells, most gene expression changes revert to original levels approximately 3 to 4 weeks after in vitro infection (Lin et al, 2000) . These findings indicate that although EBV infection probably does not initiate NPC development, it can promote proliferation.
Miller et al (Miller et al, 1995) have demonstrated that EBV gene products such as LMP-1 up-regulate EGFR gene expression. All such research has used a single gene to investigate changes in expression of host genes. However, host cell response to a single transfected viral gene may differ from that to the whole viral genome. In the course of viral infection, there is no evidence to suggest that one virion affects the expression of only one gene. Therefore, to study the physiologic response to EBV infection, it is necessary to infect cells in vitro and in vivo to obtain cellular reactions under normal physiologic conditions. Because an effective method to infect epithelial cells directly by EBV particles was not available in earlier research, study in this field has been limited. Our research is an in vitro and in vivo study that examines the effects of EBV infection on NPC progression. In vitro, we used receptor-mediated endocytosis (Lin et al, 1997a; Sixbey and Yao, 1992) to infect NPC cells and performed functional analysis to observe NPC invasiveness after EBV infection using membrane invasion culture system (MICS). In vivo, we transplanted EBVϪ NPC cells into severe combined immunodeficiency (SCID) mice. We then infected tumors with EBV. Growth-and invasionrelated gene expressions were investigated in tumors and compared with biopsy specimens.
Results

Identification of EBNA-1 and EBV Genome in EBV؉ NPC Cells
To confirm that EBV infection of NPC cells through IgA receptor-mediated endocytosis was feasible (Lin et al, 1994 (Lin et al, , 1997a and to estimate infection efficiency, we used EBNA-1 antibodies to stain infected cells and used PCR Southern blotting and in situ PCR hybridization to localize the EBV genome in infected cells. PCR Southern blotting results showed a clear 110-bp band of EBV Bam H1 W fragments (data not shown). When EBVϩ cells were fixed and stained with EBNA-1 antibody, anti-EBNA-1 reaction product was present in most tumor cells (Fig. 1A, arrows) ; a few cells had no reaction product (Fig. 1A, arrowhead) . No reaction product was present in EBVϪ cells (Fig. 1B, arrow) . Counting EBNA-1-positive cells from two EBVϩ NPC cell lines in 20 high power fields (ϫ400) yielded a 95% average infection rate. The in situ PCR hybridization study demonstrated a clear EBV DNA signal in most EBVϩ cells (Fig. 1C, arrows) ; a few infected cells had no EBV DNA signal (Fig. 1C, arrowhead ). No EBVϪ cell had an EBV DNA signal (Fig. 1D, arrow) . Counting EBV DNA-positive cells from two EBVϩ NPC cell lines in 20 high power fields (ϫ400) yielded a 95% average infection rate. These findings are similar to those in our previous reports (Lin et al, 1994; Lin et al, 1997a; Lin et al, 2000) . 
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Membrane Invasion Culture Assay for EBV؉ NPC Cells
Membrane invasion culture assay was used to analyze invasive activity of EBVϩ cells. We cultured EBVϩ and EBVϪ cells in matrigel-coated membranes and incubated them for 7, 14, and 21 days. Number of invaded cells after 7 days was 1.4 times higher in EBVϩ cultures than in EBVϪ controls. After 14 days, the number of invaded cells increased to 2.5 times higher than in controls. After 21 days, the number of invaded cells decreased to 1.4 times the control level (Fig. 2) .
Semi-Quantitative RT-PCR Analysis of Invasion-Related Gene Expression in EBV؉ NPC Cells
To observe invasion-related gene expression in EBVϩ host cells, we investigated gene expressions of three matrix proteases and two angiogenic factors. When total RNA was isolated from EBVϩ cells after incubation for 0, 7, 14, and 21 days and then subjected to RT-PCR analysis, we found that matrix metalloproteinase (MMP)-2 gene expression had been moderately up-regulated and was time dependent (Fig. 3A) . MMP-9 and heparanase also had moderate gene expression up-regulation, but their elevations were variable at different time intervals (Fig. 3, B and E). When we analyzed vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) RNA, we found that VEGF gene expression was mildly up-regulated (Fig. 3C) . bFGF expression was unchanged ( Fig. 3D ). Densitometry analysis of RT-PCR data (Fig. 4) showed that (a) MMP-2, MMP-9, and heparanase were moderately up-regulated and were either time dependent or showed variable elevations at different times; (b) VEGF (121 bp was used as the representative band) was mildly up-regulated; and (c) bFGF showed no significant change.
Growth, Morphological Changes, and EBV Genome Observations in EBV؉ and EBV؊ tumors
To investigate the behavior of EBVϩ cells in vivo, we implanted EBVϪ NPC cells into SCID mice and subsequently injected IgA anti-EBV-VCA and EBV particles into solid tumor nodules. Three weeks later, tumors that had been injected with IgA anti-EBV-VCA and EBV particles had grown faster and larger (average tumor volume [TV] ϭ 1.56 cm 3 ) than EBV-free tumor masses, including those injected with EBV only (TV ϭ 0.86 cm 3 ) or those without injection of any kind (TV ϭ 0.90 cm 3 ) (Table 2) . TV was calculated using the formula: TV ϭ L ϫ W 2 ϫ 0.5. (L and W represent tumor length and width, respectively.)
Hematoxylin and eosin staining of EBVϩ and EBVϪ tumor sections from the NPC-TW01 line showed keratinizing squamous cell carcinoma with areas of nonkeratinizing undifferentiated tumor cells (data not shown). Mitotic and apoptotic cells were seen more Analysis of invasive ability of nasopharyngeal carcinoma cells using MICS. The invasive abilities of cells were measured in vitro with the membrane invasion culture system chamber as described in Materials and Methods. NPC-TW01 cells (2.5 ϫ 10 3 ) after EBV infection in vitro were seeded on Matrigel, and invaded cells were examined after 48 hours. EBVϩ cells were incubated for 0 day (A), 1 week (B), 2 weeks (C), and 3 weeks (D). Bar graphs represent average % of invasiveness compared with control cells ϩ standard error: A ϭ 100 Ϯ 11.5%; B ϭ 140 Ϯ 13.7%; C ϭ 254 Ϯ 19.7%; and D ϭ 136 Ϯ 17.2%. Semi-quantitative RT-PCR analysis of invasion-related host gene expressions in EBVϩ NPC cells. After EBV infection in the in vitro culture system as mentioned in Figure 1 , NPC cells were cultured for 1, 2, and 3 weeks and harvested for total RNA extraction for RT-PCR analysis. (A) MMP-2, (B) MMP-9, (C) VEGF, (D) bFGF, and (E) heparanase. The 133-bp MMP-2 band, the 640-bp MMP-9 band, and the 585-bp heparanase band show increased intensity (Ͼ ϫ2.5) when incubation time was increased from 0 weeks to 3 weeks. After incubation for 3 weeks, intensities of the 165-and 121-bp VEGF bands only slightly increased (Ͼ ϫ2.5) and of the 237-bp bFGF band showed no remarkable change.
Figure 4.
Densitometry analysis of EBV-related host gene expressions. Data were obtained from gel electrophoresis analysis in Figure 3 . Each gene expression shows four different bars. From left to right, they represent the different EBV-infection periods of 0, 1, 2, and 3 weeks, respectively. Matrix metalloproteinase (MMP)-1, MMP-9, and heparanase show moderate gene expression elevation (Ͼ ϫ2.5) after EBV infection and incubation for 3 weeks. VEGF gene was mildly up-regulated (ϫ1.5 to ϫ2.5). bFGF was minimally changed (Ͻ ϫ1.5).
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Laboratory Investigation • June 2003 • Volume 83 • Number 6 often in EBVϩ and less often in EBVϪ tumor sections. In EBVϩ tumor sections, average numbers of mitotic cells and apoptotic cells were 9 and 13 cells per high power field (ϫ400), respectively. In EBVϪ tumor sections, average numbers of mitotic cells and apoptotic cells were 7 and 12.8 cells per high power field, respectively. Averages were obtained from 20 high power field counts. When total DNA was extracted from randomly selected fragments of each EBVϩ tumor, some had a 110-bp band of EBV DNA in BamHI fragments by PCR Southern blotting, similar to in vitro observations. Tissue fragments from other tumors had no EBV signal (Table 2) . If in situ hybridization was used to identify EBER-1 in tumor cells, some tissue fragments were positive for EBV, while others were negative (Table 2) . Nevertheless, all were positive for EBV by either PCR Southern blotting or in situ hybridization, or by both (Table 2) . Different EBVϩ or EBVϪ results in tissue fragments were mainly due to the EBV infection method used in which both IgA anti-EBV-VCA and EBV particles were injected separately and directly into solid tumor masses. Distributions of bFGF, basic fibroblast growth factor; MMP, matrix metalloproteinase; VEGF, vascular endothelial growth factor. a All the primers' sequences were adapted from published reports in the Reference column. The primers for epidermal growth factor receptor, TGF-␣, TGF-␤1, TGF-␤R1 TGF-␤RII, secretory component, and the internal control GAPDH and actin sequences were used as in our previous report (Lin et al, 2000) . 
a EBV-free NPC-TW01 cells (1 ϫ 10 7 ) were injected into 10 SCID mice. Seven days later, five mice were injected with IgA anti-EBV and EBV particles, separately, two with EBV particles only, directly into the solid tumor masses; another three were kept without any treatment. The tumor masses were dissected after another 3 weeks.
b Solid tumors injected with EBV particles only. Animals were killed at 28th day after they were injected with tumor cells. c Solid tumors injected with IgA anti-EBV ϩ EBV particles. All animals were killed at 28th day after they were injected with tumor cells. d Solid tumors without any treatment. All animals were killed at 28th day after they were injected with tumor cells. e Tumor size was calculated by length ϫ (width) 2 ϫ 0.5.
EBVϩ and EBVϪ tumor cells were different in each tumor mass in in situ hybridization. EBVϩ cells were seen mostly surrounding the injected site (Fig. 5 , A and C). Many EBVϩ cells were intermixed with EBVϪ cells and showed clonal proliferation (Fig. 5B , between two arrows). In some tumor nests, the central differentiated region contained fewer EBVϩ cells (Fig. 5D , small arrows). Some EBVϩ (Fig. 5D , large arrowhead) and EBVϪ (Fig. 5D , large arrow) differentiated tumor cells also showed apoptotic change. If tumor was injected with EBV only, without IgA anti-EBV, no EBV signal was present (Fig. 8B) .
Identification of Clonal EBV Terminal Sequence Repeats in EBV؉ Solid Tumor Masses
To see if the in vitro finding that EBVϩ NPC cells had a clonal EBV genomic DNA sequence (11) was present in the in vivo animal model, we examined solid tumor masses removed from two SCID mice that had been injected with NPC-TW01 and 06 cells and infected by EBV (IgA anti-EBV-VCA ϩ EBV). We subjected tumors to total DNA isolation. For comparison, we examined tumors obtained from a SCID mouse that had been injected with NPC cells and EBV only (without IgA). In addition, total DNA isolated from the Raji and the B95-8 cell lines were also examined. All DNA samples were analyzed by Southern blotting using a 32 Plabeled XhoI 1.9 kb DNA fragment probe (Lin et al, 1997b) . B95-8 cells had multiple bands of terminal repeats and a major 18-to 30-kb band ( Lin et al, 1997b revealed two well-separated gels and showed the same major 15-to 20-kd band). This band may be derived from fused termini bands.
Host Gene Expressions Changes in EBV؉ Tumors
Because EBVϩ tumors grew faster and larger than EBVϪ tumors, we examined expression of growth factor related genes. EGFR and TGF-␣ gene expressions were increased in EBVϩ tumors. A representative gel analysis is shown in Figure 7A . TGF-␤1, TGF-␤ receptor-I, and TGF-␤ receptor-II gene expressions were not significantly different in EBVϩ and EBVϪ tumors (data not shown). In our previous report (Lin et al, 1997a) , we presented data indicating that in vitro EBV infection can suppress SC protein. We wanted to know whether this phenomenon occurred in our animal model. RT-PCR analysis of SC-mRNA expression demonstrated marked down-regulation of SC gene expression in EBVϩ tumors (Fig. 7B ), similar to our previous in vitro experiment (Lin et al, 1997a) . To confirm the presence of overexpressed EGFR and underexpressed SC mRNA, we used antibodies against EGFR and SC to stain tumor sections. Enhancement of EGFR immunostaining was clearly evident in EBVϩ tumors. Many cells had a strong staining reaction, and a small number had no staining reaction (Fig. 8A ). When antibodies against SC protein were used, SC immunostaining was almost invisible in EBVϩ tumor sections (data not shown).
Co-Localization of EBV and Host Gene Expressions in Solid Tumors from SCID Mice
To investigate the relationship of the EBV genome with growth and invasion related gene expressions in EBVϩ cells in solid tumors, we performed doublelocalizations of host proteins and EBER-1. In EBVϩ tumor sections, many cells tested positive for EBV, and only a fraction were strongly EGFR immunoreactive ( Fig. 8A , arrowhead). Many EBVϩ cells showed no EGFR immunoreactivity (Fig. 8A, arrow) . In EBVϪ tumor sections, only certain cells had moderate EGFR immunoreactivity (Fig. 8B , large arrowhead), and other cells had no EGFR staining (Fig. 8B , small arrowhead). In situ hybridization of EBER-1 in the same EBVϪ sections showed no EBV signal (Fig. 8B) .
When MMP-2 and EBER-1 were co-localized in EBVϩ sections, most cells showed no or nonspecific background staining (Fig. 8C , black arrowhead); only a few clearly had immunostaining (Fig. 8C , large white arrowhead). However, many interstitial mesenchymal cells were strongly immunoreactive (Fig. 8C, arrow) . In EBVϪ tumor sections, only a few tumor cells were immunostained (Fig. 8D , arrows) and most were stainfree (Fig. 8D , small arrowhead). Many interstitial mesenchymal cells also contained anti-MMP-2 immunostaining (Fig. 8D, large arrowhead) .
In the case of MMP-9, many EBVϩ cells had strong anti-MMP-9 immunostaining (Fig. 8E, arrow) , but others did not (Fig. 8E, arrowhead) . Similarly, in EBVϪ tumor sections, many cells had anti-MMP-9 immunostaining (Fig. 8F, arrow) , but others did not (Fig. 8F,  arrowheads) . These finding are similar to those with regard to EGFR expression in EBVϩ and EBVϪ tumor sections. Interstitial mesenchymal cells in both sections were rarely stained (Fig. 8, E and F) .
With regard to VEGF co-localization, many EBVϩ cells were anti-VEGF immunoreactive (Fig. 9A , arrowheads), and a few were not (Fig. 9A, single arrows) . Immunoreactivity was also seen on or in vascular walls and in endothelial cells (Fig. 9A, double arrows) . In EBVϪ sections, anti-VEGF immunoreactivity was also seen in some tumor (Fig. 9B, large arrowhead) and endothelial cells. Some tumor cells had no or very weak staining (Fig. 9B, small arrowhead) .
In the case of bFGF, only some EBVϩ cells contained bFGF immunoreactivity (Fig. 9C , large white arrowhead); many others were free of bFGF immunostaining (Fig. 9C , small white arrowhead). In EBVϪ sections, only certain tumor cells contained bFGF reaction product (Fig. 9D, arrowhead) , a finding similar to that in EBVϩ sections; all tumor cells were EBVϪ (Fig. 9D, arrow) . The average numbers of EBVϩ cells and cells containing each antiprotein reaction product are shown in Tables 3 to 7. They were obtained by counting 15 high power fields (ϫ400) in all doublelocalization sections.
Western Blot Analysis of EGFR Protein Expression in EBV؉ Tumors
Although different staining intensities could easily be identified in EGFR immunohistochemical localizations in EBVϩ sections, it was difficult to quantify levels of EGFR expression. Therefore, we used routine Western blot analysis to examine EGFR expression levels. We found that EGFR protein expression in EBVϩ cells was 1.7-fold higher than in EBVϪ cells. (Fig. 10) .
Co-Localization of EBV and Host Gene Expressions in NPC Biopsy Specimens
To confirm observations from xenograft tumor masses dissected from SCID mice, we collected 20 NPC primary biopsy specimens that had been examined by PCR and Southern blotting previously and that had tested positive for EBV infection. Paraffin block sections were then examined.
After performing in situ hybridization using EBER-1 antisense probe, we found that all NPC specimens had some EBVϩ and EBVϪ tumor cells (Fig. 11, B to F) . When sections were examined by in situ PCR hybridization, similarly some EBVϩ cells (Fig. 11A, arrows) and EBVϪ cells (Fig. 11A , large and small arrowheads) were also found. Both methods had produced similar results. In some cases, sections contained more EBVϩ cells and in others more EBVϪ cells. Average EBVϩ cell numbers in 20 biopsy specimens by in situ hybridization and in situ 
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PCR hybridization methods were similar and ranged between 72% and 82%. These data were obtained by averaging EBVϩ cell numbers in each of 20 cases. EBVϩ cell numbers were obtained from 15 high power field (ϫ400) counts. Two to five representative NPC cases (WHO Type I, keratinizing squamous cell carcinoma or WHO Type IIb, undifferentiated carcinoma) were used for co-localization of EBV with EGFR, matrix proteinases, and angiogenic factors. When NPC biopsy specimens were co-localized with EBER-1 and EGFR protein, some EBVϩ cells contained EGFR immunoreactivity (Fig.  11B , large white arrowhead), while others did not (Fig. 11B, small white arrowhead) . In EBVϪ cells (Fig. 11B , small black arrowhead), there were instances of EGFR immunostaining (Fig. 11B , large black arrowhead).
If biopsy sections were stained with MMP-2 and EBER-1, only a small fraction of cells showed the EBER-1 signal (Fig. 11C, white arrowhead) . EBVϩ cells very rarely expressed MMP-2. Very few EBVϪ tumor cells (Fig. 11C , small black arrowhead) contained MMP-2 reaction product (Fig. 11C , large black b The average of percentage was obtained from two NPC biopsy specimens. c In each case, the average of stained cell number was obtained from the average of 20 high power field counts (ϫ400).
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In the case of MMP-9, certain EBVϩ and EBVϪ tumor cells showed MMP-9 immunoreactivity (Fig.  11D , short arrow; and Fig. 11D , inset black arrowhead), but anti-MMP-9 immunoreactivity was also seen in interstitial mesenchymal and mononuclear cells (Fig. 11D, long arrows) . Some EBVϩ tumor cells showed no MMP-9 immunoreactivity (Fig. 11D, small  arrowhead) .
When VEGF antibodies and in situ hybridization of EBER-1 were applied to NPC specimens, VEGF immunoreactivity was seen in EBVϩ cells (Fig. 11E , arrow) and in certain EBVϪ cells (Fig. 11E , large black arrowhead). Furthermore, a fraction of tumor cells were EBVϪ and VEGF-negative (Fig. 11E , small black arrowhead).
When anti-bFGF and in situ hybridization of EBER-1 were applied to NPC specimens, some cells were bFGF reactive (Fig. 11F , large black and large white arrowheads). Only some of these bFGF reactive cells contained the EBV signal (Fig. 11F , large white arrowhead). Many bFGF unreactive cells had the EBV signal (Fig. 11F, small white arrowhead) . However, certain tumor cells were neither EBV-DNA nor bFGF immunoreactive (Fig. 11F, small black arrowhead) .
Average numbers of EBVϩ cells and cells containing specific proteins in biopsy specimens are shown in Tables 3 to 7 . Because antibodies for heparanase were not available, we did not perform immunostaining for heparanase.
Discussion
Patients who have undifferentiated NPC usually have high titers of IgA anti-EBV-VCA, especially if the tumor is infected by EBV. In many cases, EBVϩ tumors have grown faster and larger than EBVϪ tumors. In addition, in situ hybridization of EBER-1 and in situ PCR hybridization of BamH1 W fragments in NPC biopsy specimens all reveal clonal expansion of EBVϩ tumor cells, which are surrounded by EBVϪ tumor cells. This indicates that EBV infection can accelerate NPC cell proliferation (Lin et al, 1994 (Lin et al, , 1997a . To support this hypothesis, we analyzed the function of EBV in NPC cells.
For in vitro investigation, we used the IgA receptormediated endocytosis method to infect NPC cells with EBV. Infection efficiency was 90% to 95% in three different cell lines and depended on degree of SC protein expression. Then, we used an MICS to examine degrees of cell invasion and migration after NPC cells had been infected with EBV for different time intervals. Our results (Fig. 2) indicate that EBV infection enhances NPC cell migration and invasion in vitro and that degree of invasion is time dependent. After 21 days, tumor cell invasion and migration decreased because many EBV genomes had been excreted through exocytosis. All EBV DNA became undetectable by PCR analysis 72 days after infection (Lin et al, 2000) .
The mechanism of tumor cell invasion and migration enhancement was investigated by RT-PCR analysis of bFGF, basic fibroblast growth factor; NPC, nasopharyngeal carcinoma. a In each case, the average of stained cell number was obtained from the average of counting 15 high power fields (ϫ400).
b The average of percentage was obtained from three NPC biopsy specimens.
c In each case, the average of stained cell number was obtained from the average of counting 20 high power fields (ϫ400).
Figure 10.
Western blot analysis of epidermal growth factor receptor (EGFR) protein expression in EBVϩ and EBVϪ NPC-TW04 cells. In the upper panel, the 170-kD band of EGFR is stronger in EBVϩ cells than in EBVϪ cells. The densitometry analysis from gel electrophoresis in the lower panel indicates a 1.7-fold increase of EGFR in EBVϩ cells.
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Figure 11.
Localization of EBV genome by in situ PCR hybridization and co-localization of epidermal growth factor receptor (EGFR) ϩ EBER-1, matrix metalloproteinase (MMP)-2 ϩ EBER-1, MMP-9 ϩ EBER-1, vascular endothelial growth factor (VEGF) ϩ EBER-1 and basic fibroblast growth factor (bFGF) ϩ EBER-1 in nasopharyngeal carcinoma (NPC) biopsy specimens. invasion-related host gene expressions. Both RT-PCR data (Fig. 3) and densitometry analysis (Fig. 4) suggest that MMP-2, MMP-9, and heparanase gene expressions are moderately up-regulated, that VEGF is mildly up-regulated, and that all are time dependent with some variation. The fact that these four RNA gene expressions were still up-regulated 3 weeks after EBV infection indicates that their mRNA may have a longer half-life, similar to that of GM-CSF gene expression, which was also up-regulated 3 weeks after infection, as shown in our previous report (Lin et al, 2000) . In that study, we demonstrated that growth factor and cytokine genes, such as EGFR, TGF-␣, IL-1, and IL-6, were up-regulated at 2 and 3 weeks and were decreased after 4 weeks of EBV infection, at which time a fraction of infected cells still contained copies of EBV genome. No EBV genome can be detected after 72 days. Although we did not include a 4-week incubation in the present experiment, we believe that mRNA expression of EGFR, heparanase, MMP-2, and MMP-9 would decrease after 4 weeks because of EBV genome excretion. These data suggest that EBV may not directly regulate these genes. It is likely that EBV proteins enhance these host gene expressions indirectly. There was no significant elevation of bFGF gene expression.
For in vivo investigation of EBV function in infected NPC cells, we established an animal model. In this model, we demonstrated that EBVϩ tumors grew faster and larger than EBVϪ ones (Table 2 ). This finding suggests that EBV accelerates NPC tumor growth in vivo in SCID mice and differs from the hypothesis that EBV may be involved in initiation or early promotion of NPC tumorigenesis (Pathmanathan et al, 1995; Raab-Traub and Flynn, 1986) . The argument that EBV initiates and promotes NPC tumorigenesis is based on molecular and morphologic findings from NPC patients and biopsy specimens, which can be summarized as follows: (a) Many NPC biopsy specimens contain the EBV genome with a clonal terminal repeat pattern (Raab-Traub and Flynn, 1986) , and (b) Many NPC patients have high titers of IgA for EBV-VCA and other antigens. It was deduced that EBV infects and transforms nasopharyngeal squamous metaplastic epithelial cells. During clonal proliferation of transformed epithelial cells, EBV episomal plasmids replicate and produce the EBV genome with a clonal terminal repeat pattern. It was concluded that EBV participates in early carcinogenesis of NPC (Pathmanathan et al, 1995; Raab-Traub and Flynn, 1986) .
However, our animal experiment and observations from NPC biopsy specimens do not support this conclusion; rather, they indicate that EBV plays another role by regulating enhancement of NPC tumor growth. This conclusion is based on the observation that analysis of EBV terminal repeat sequences in EBVϩ tumors demonstrated that all tumors had a clonal (single band) EBV terminal repeat sequence that differed in size if different cell lines were examined. This finding goes against the hypothesis that a clonal EBV terminal repeat sequence can only be observed in a single epithelial cell transformed by EBV, thereby resulting in clonal proliferation of tumor cells (RaabTraub and Flynn, 1986) . This hypothesis is also not supported by our previous in vitro study that demonstrated a clonal EBV terminal repeat sequence in NPC cells infected by an EBV-IgA-SC complex (Lin et al, 1997b) . It is apparent that epithelial NPC tumor cells infected in vivo by multiple EBV particles can also have a clonal EBV terminal repeat sequence. Therefore, we feel that a clonal EBV terminal repeat sequence does not fully explain NPC tumorigenesis. It should be pointed out that although single bands in lanes 3 and 4 (Fig. 6) could be explained by a single integration event after loss of all episomes, we feel such an event is unlikely.
In a previous experiment (Lin et al, 1997b ; Fig. 4) , we collected the total DNA from EBVϩ NPC cells. It was digested by BamH1 endonuclease and hybridized by XhoI 1.9 kb and LMP2B probes. Results yielded EBV genomes of the same size, a finding that indicates EBVϩ NPC cells contain an episomal form of the viral genome. Because this result has been published, we have not included the data in the present study. Our previous data have also shown that when EBV particles isolated from the B95-8 cell line were used to immortalize normal human peripheral lymphocytes, Southern blot analysis of EBV DNA in these lymphocytes demonstrated a polyclonal terminal repeat sequence with one major 15-to 20-kb band (Lin et al, 1997b) . In the present experiment, we also performed Southern blot analysis of B95-8 cell line DNA and found multiple bands plus one major 18-to 30-kb band. The size of this major band is probably due to fusion of different termini and to the shorter gel electrophoresis time. Both methods show the same polyclonal EBV termini sequences. These results can be explained on the basis of differences in EBV particle behavior in different cell types. When EBV particles infect B lymphocytes, the linear form of EBV DNA fuses randomly to form the circular form. When EBV particles infect epithelial tumor cells, they may fuse randomly at first to form the circular form; within a short period of time, some cells that contain a specific size of circular form may proliferate faster than the cells that contain other circular form, resulting in the presence of a same size of circular form in the majority of infected cells; on the other hand, all infected linear forms may fuse at a same specific site in the epithelial cells. Under these circumstances, EBV genomes produced in B lymphocytes form polyclonal DNA sequences, while those produced in epithelial tumor cells form clonal DNA sequences. However, further experiment is needed to prove it.
EBV enhancement of NPC tumor growth in vivo may be due to the fact that EGFR, TGF-␣, and unidentified growth factors are up-regulated in EBVϩ cells. This is shown in the present animal experiment using RT-PCR and in a previous study in which in vitro EBV infection of NPC cells demonstrated up-regulation of EGFR and TGF-␣ (Lin et al, 2000) . Previously, Miller et al (Miller et al, 1995) reported that EBV-LMP-1 protein induced EGFR expression in a uterine cervical cancer cell line that had been transfected with a plasmid containing the LMP-1 DNA sequence. However, in the present experiment, average numbers of EBVϩ and EBVϪ tumor cells that expressed EGFR in solid tumor sections were similar: 73 and 75, respectively. Immunostaining of EGFR was much stronger in EBVϩ than in EBVϪ sections. This finding was supported by Western blot analysis of EGFR expression in EBVϩ and EBVϪ cells, which showed that EBVϩ cells had 1.7-fold increase in EGFR protein (Fig. 10) .
It is possible that in the present animal experiment (although some NPC cells already expressed EGFR mRNA and protein), LMP-1 produced from EBVϩ cells could also up-regulate the expressed EGFR gene. In those cells that did not express EGFR in EBVϪ tumor masses, EBV infection could not cause expression of the unexpressed EGFR gene (Fig. 8, A and B) . The results from EGFR expression in the EBVϩ and EBVϪ tumor cells in the in vitro and in vivo animal model and in the biopsy specimens (Fig. 11B ) all suggest that EBV up-regulates EGFR only in cells that express EGFR, but not in cells that do not express EGFR. Because the present experiments were not designed to prove this assumption, this hypothesis needs further study. Although we feel that EBV enhances NPC progression, our experiment does not rule out a role for EBV in the initiation and promotion of NPC carcinogenesis. The finding that many biopsy specimen tumor cells that expressed strong EGFR were not infected by EBV (Fig. 11B) indicates that EGFR expression may be up-regulated both by EBV infection and by other unidentified factors.
The distribution of EBV-containing NPC cells (clonal proliferation) in sections of solid tumor (Fig. 5B) suggests that EBVϩ cells grow faster than EBVϪ cells. It should be pointed out that cells derived from a mother cancer cell are genetically unstable and have different genotypes and phenotypes with variable growth characteristics. Therefore, EBV infection of tumor cells variably affects growth patterns. EBV up-regulates EGFR and TGF-␣ gene expression but not TGF-␤ and its receptor gene. Thus, only a subset of EBVϩ cells may grow faster than other infected cells. Alteration of other growth factor genes in EBVϪ tumor cells could enhance their proliferation as well. If these cells were later infected by EBV, marked enhancement of tumor growth by up-regulated expression of other growth factor related genes could occur.
Because increased expression of matrix proteinases and angiogenic factors is needed for tumor invasion and proliferation, we evaluated EBV tumor growth promotion by studying two proteases associated with EBV infection: MMP-2 and MMP-9 (Horikawa et al, 2000; Takeshita et al, 1999; Yoshizaki et al, 1998) . We also studied VEGF and bFGF because they are well known factors in angiogenesis. The moderate elevation and time-dependent expression of MMP-2 mRNA demonstrated by RT-PCR analysis indicate that EBV up-regulates MMP-2 expression. This finding is supported by double-localization data in tumor sections from SCID mice (Fig. 8, C and D) . However, it should be pointed out that background staining presented difficulties in differentiating MMP-2-positive cells from MMP-2-negative cells (Fig. 8C ) Therefore, only those tumor cells with clear immunostaining were considered MMP-2 positive. Furthermore, the strongly positive reaction of stromal mesenchymal cells suggests that EBV induces host cell transcription of unidentified growth factors and cytokines, which up-regulate MMP-2 gene expression, probably through a paracrine effect. Results from NPC biopsy specimens demonstrated that some EBVϩ cells did not express MMP-2, an indication that EBV cannot activate the unexpressed MMP-2 gene in host cells (Fig. 10C) .
In the case of MMP-9, EBV up-regulated MMP-9 expression in in vitro EBVϩ cells and in in vivo EBVϩ solid tumors. Furthermore, in the NPC biopsy specimens, MMP-9 protein expression was increased in stromal mesenchymal cells. The strong MMP-9 expression in these cells may not be related to EBV infection. It is possible that NPC cells secrete growth factors and cytokines that stimulate stromal cells. The fact that some EBVϩ cells in NPC biopsy specimens contained no MMP-9 protein (Fig. 11D) suggests that EBV does not activate the unexpressed MMP-9 gene. The fact that some EBVϪ tumor cells were MMP-9 positive indicates that MMP-9 expression is regulated by other factors.
Recently, Takeshita et al (Takeshita et al, 1999 ) have demonstrated up-regulation of endogenous MMP-9 gene expression and exogenous MMP-9 promoter activity in a uterine cervical cancer cell line transfected by wild-type LMP-1. They concluded that activation of NF-kB and AP-1 pathways by LMP-1 is necessary for activation of MMP-9 expression. We found that certain NPC cells in both xenograft tissue sections and NPC biopsy specimens showed up-regulated MMP-9 expression in cells infected by EBV. Our data support the findings of Takeshita et al (Takeshita et al, 1999) . Because our study showed EBVϩ tumor cells in xenograft and NPC biopsy specimens without MMP-9 expression (Figs. 8 and 10) , the results of a transfection experiment on a cell line without MMP-9 expression would be pertinent to our research.
Based on findings from in vitro RT-PCR analysis of EBVϩ cells (Figs. 3C and 4) , in vivo EBVϩ SCID mouse tumor sections (Figs. 9, A and B) and NPC biopsy specimens (Fig. 11E) , we propose that EBV regulates VEGF gene expression. However, because some EBVϩ cells did not express VEGF, we also suggest that EBV does not activate the unexpressed VEGF gene. Since RT-PCR analysis showed no significant differences in bFGF expression in EBVϩ and EBVϪ cells, we believe EBV has little or no role in the regulation of bFGF expression (Figs. 3D, 4, and 11F) . Recently, Vlodavsky et al (Vlodavsky et al, 1999) have proposed that heparanase is an important protease involved in tumor invasion. In our RT-PCR analysis of heparanase expression in EBVϩ and EBVϪ cells, we found that EBV infection moderately up-regulated heparanase expression (Figs. 3E and 4) . We suggest that heparanase enhances NPC cell invasion. This proposal needs further investigation. In conclusion, EBV enhances NPC cell proliferation, invasion, and tumor growth by up-regulating EGFR, TGF-␣, MMP-2, MMP-9, VEGF, and other unidentified genes in cells that express those genes. However, EBV does not up-regulate EGFR, MMP-2, MMP-9, VEGF, and bFGF in cells that do not express these genes. Although we feel that EBV enhances NPC progression, our experiment does not rule out a role for EBV in the induction and promotion of NPC development. Furthermore, unidentified factors may enhance NPC proliferation independent of EBV infection.
Materials and Methods
Cell Lines and Culture
In this experiment, we used two representative NPC cell lines established in our laboratory (NPC-TW01 and 06). NPC-TW01 (Lin et al, 1990 ) was derived from a 64-year-old male NPC patient with keratinizing squamous cell carcinoma (WHO Type I) and NPC-TW 06 (Lin et al, 1993) were derived from a 58-year-old female NPC patient with an undifferentiated carcinoma (WHO Type IIb). Although the lines contained EBV DNA at early passages, they became negative after 30 passages (Lin et al, 1994) .
EBV Infection of NPC Cells
EBV particles isolated from a B95-8 cell line were used to infect NPC cells according to the method of receptor mediated endocytosis as previously described (Lin et al, 1997a; Sixbey and Yao,1992) . Briefly, NPC-TW01 (WHO Type I) and NPC-TW04 and 06 (WHO Type IIb) cells were incubated with diluted (1:50 dilution) NPC patient serum containing high titer (1:640) of IgA anti-EBV-VCA at 4°C, separately, for 30 minutes. After washing, EBV particles were added, and the cells were re-incubated for another 30 minutes at 4°C, and then transferred to a CO 2 incubator, incubated at 37°C for 30 minutes. Finally, the regular culture medium (DMEM ϩ 5% FCS) was used, and the cells were cultured for 21 days. Some tumor cells were collected on Day 7, 10, 14, and 21 and subjected to in vitro invasion assay (Chu et al,1993) , semi-quantitative RT-PCR analysis (Lin et al, 2000) ; and others were checked by PCR Southern blotting and in situ PCR hybridization (Lin et al, 1994) to make sure that the infection process was complete. To be sure that NPC cells could only be infected by IgA anti-EBV-VCA ϩ EBV particles, we further divided the NPC cells into two groups: one group was treated with high titer of NPC antiserum IgA anti-EBV-VCA and EBV particle as mentioned above, and the other group was treated with EBV only. Both groups were further incubated for 7 days. Then part of each group was fixed for in situ PCR hybridization; another part of each group was fixed for immunostaining using mAb against EBNA-1 as we have done previously (Lin et al, 2000) .
Tumor Invasion Assay
To investigate the NPC cell invasion ability, we used MICS (Chu et al, 1993; Hendrix et al, 1987) . It is a multifaceted system to examine a number of steps involved in cell invasion and migration. We used 10-m pore size of a nitrocellulose membrane coated with a mixture of 5 mg/ml matrigel, applied 2.5 ϫ 10 4 NPC-TW01 cells after EBV infection for 0, 7, 14, and 21 days, separately, and incubated in DMEM containing 10% Nuserum for 48 hours. The invaded cells were then fixed and stained with propidium iodide and counted with computer software under a magnification of ϫ50. The experiments were repeated three times.
Semi-Quantitative RT-PCR Analysis of Gene Expressions Related to Tumor Invasive Proteases and Angiogenic Factors in EBV-Infected NPC Cells
We selected MMP-2, MMP-9, and heparanase as representative matrix proteases, and used VEGF and bFGF as representative angiogenic factors to investigate their gene expressions in EBV-infected NPC cells. The procedure of RT-PCR, including the isolation of total RNA, reverse transcription, and PCR analysis, was performed according to our previous publication (Lin et al, 2000) . The primers we used are shown in Table 1 . Two pairs of actin primer sequences (one includes 318 bp and the other 173 bp) were used for internal control. The sequences were exactly similar to our previous publication (Lin et al, 2000) . The results from gel analysis of RT-PCR were further analyzed by densitometry.
Establishment of the SCID Mouse Model Bearing with EBV-Infected NPC Tumors
EBV-free NPC cells (1 ϫ 10 7 cells per mouse) were injected into 10 SCID mice subcutaneously. Seven days later, the tumor masses (about 0.5 cm in diameter) in each of five mice were injected directly with IgA-anti-EBV-VCA (0.2 ml of ϫ50 diluted NPC patient serum) and 0.2 ml of ϫ100 concentrated EBV solution (EBV solution was obtained from ϫ100 concentrated B95-8 cell culture medium), separately. After another 21 days, the tumor masses were removed, measured, and dissected into several pieces and randomly subjected to identification of EBV genome and tumor gene expressions. In each of another two mice, the tumors were injected with EBV only without IgA as the EBV-free control group. In another three mice, each tumor mass did not injected with any substance, as a negative control.
For identification of EBV genome in the solid tumor masses removed from the SCID mice, total DNAs from each mass were isolated by SDS lysis, proteinase K digestion, and phenol-chloroform extraction and subjected to PCR and Southern blotting using BamH1 W fragment of EBV genomic DNA (Lin et al, 1994) as the probe. We also applied in situ PCR hybridization (Lin et al, 1994 (Lin et al, , 1997a ) using a two-step method. The first step was to perform in situ PCR (the PCR primers were designed from BamH1 W fragment). The second step was to perform in situ hybridization (using the DNA fragment as the probe, which was derived from the inner region of two primers in BamH1 W fragment and labeled with digoxigenin) to localize EBV genome in the tumor sections, and in situ hybridization using the EBER-1 (EBV encoded small nuclear RNA-1) antisense probe to detect the EBV small nuclear RNA (Lin et al, 1994) to see whether the infected EBV could still transcript its mRNA. For identification of the EBV terminal repeat sequences in the solid tumor mass, we used BamHI endonuclease to digest DNA, and subjected it to Southern blotting using the XhoI 1.9 kb in the right terminus region of EBV genome as the probe (Lin et al, 1997b; Raab-Traub and Flynn, 1986) .
Identification of Changes in Gene Expressions in EBV-Infected NPC Tumors from SCID Mice by RT-PCR
Semi-quantitative RT-PCR analysis (Ausubel et al, 1988; Lin et al, 2000) was used to detect the changes in mRNA expressions of growth factor genes and one SC protein gene. These included EGFR, TGF-␣, TGF-␤, TGF␤R-I, TGF␤R-II, and SC protein genes. Total RNAs were extracted from EBV-infected and EBV-free solid tumor masses (Lin et al, 1994 ) and subjected to reverse transcription. The cDNAs were used as the template for a touch-down PCR program (Lin et al, 2000) . The final PCR reaction product was analyzed by gel electrophoresis. In each experiment, a pair of actin or glyceraldehyde phosphate dehydrogenase primers as the internal control was included. The sequence of PCR primers was exactly similar to our previous publication (Lin et al, 2000) .
Western Blot Analysis of EGFR Expression in EBV-Infected and EBV-Free NPC Cells
After NPC-TW04 cells were infected by EBV as mentioned above for 7 days, the total protein was extracted from the same numbers of EBV-infected and EBV-free NPC cell pellets by direct mixing with denature sample buffer and subjected to 10% SDSpolyacrylamide gel electrophoresis. Routine Western blotting (Lin et al, 1993) was performed using antibodies against EGFR or tublin for internal control.
Double-Localization of Growth Factors and Tumor Invasion Factors in EBV-Infected and EBV-Free Solid Tumors Obtained from SCID Mice and NPC Biopsy Specimens
The procedure for double-localization of protein and EBER-1 was performed according to our previously published method (Lin et al, 1997a) . Briefly, the tumor masses obtained from the SCID mice were fixed in 3% formaldehyde, dehydrated, and embedded in paraffin blocks. The paraffin sections, after deparaffinization, were preheated or not and then first incubated with antibodies against EGFR, MMP-2, MMP-9, VEGF, and bFGF, separately, followed by biotinylated second antibodies and avidin-biotin peroxidase complex, and finely subjected to peroxidase substrate treatment according to the routine method. The sections were further subjected to in situ hybridization of EBER-1 according to our previously published procedure (Lin et al, 1997a ).
For double-localization in biopsy specimens, 20 NPC biopsy paraffin blocks were collected from the recent surgical biopsy file from the Department of Pathology at National Taiwan University Hospital. Eighteen cases were WHO Type IIb undifferentiated NPC, and two cases were WHO Type I keratinizing squamous cell NPC. The male to female ratio was 3:1. The range of age was between 35 to 55 years old. All were the primary biopsy specimens. Seventy percent of these patients showed neck lymph node metastasis only. The most common clinical symptoms included neck lymph node enlargement, nasal obstruction, nasal bleeding, one side tinnitus, bloody sputum, oneside facial nerve impairment and one-side headache. All specimens were subjected to EBER-1 in situ hybridization and in situ PCR hybridization using the method previously described (Lin et al, 1994; Lin et al, 1997a) . In addition, some of them (two to three cases) were subjected to co-localization of EGFR, MMP-2, MMP-9, VEGF, and bFGF, with EBER-1, separately.
